Strategic Communications and Marketing News Bureau

Burke elected to National Academy of Medicine

CHAMPAIGN, Ill. — Dr. Martin D. Burke, a University of Illinois Urbana-Champaign professor of chemistry and of the Carle Illinois College of Medicine, has been elected to the National Academy of Medicine. Election to NAM “is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service,” according to the Academy’s announcement.

Burke was elected for “creating a modular molecular synthesis platform with broad applications in health science and technology, including his pioneering research on molecular prosthetics for cystic fibrosis, and for helping mitigate the spread of COVID-19 with saliva-based testing.”

Burke pioneered a class of chemical building blocks, now commercially produced and used in many labs, and an automated molecule-making machine that puts the blocks together to synthesize small molecules and create derivatives simply and quickly. This enabled a new field of “molecular prosthetics” with the goal of treating currently incurable diseases caused by a loss of protein function with small molecules that can do the same jobs. His work already has made steps toward new treatments for cystic fibrosis and certain severe anemias.

Burke, the May and Ving Lee Professor for Chemical Innovation, also was a leader of the SHIELD team at Illinois that created and implemented a saliva-based test for COVID-19. Broad implementation of this test enabled the campus to remain open for in-person instruction from fall 2020 onward through the pandemic, and the test now is used by universities, K-12 schools and organizations across the country.

“Professor Burke’s election is well-deserved recognition of his pioneering research methods. It is a testament to his unwavering focus on finding solutions that can directly and immediately impact people’s lives and the health of our entire communities,” Chancellor Robert J. Jones said. “We are very proud of Professor Burke, and this is a cause for celebration for all of us here at Illinois.” 

Burke earned a B.A. in chemistry from Johns Hopkins University in 1998, a Ph.D. in chemistry from Harvard University in 2003 and an M.D. from Harvard Medical School in 2005. He joined the faculty at Illinois in 2005. He also is a professor in the Beckman Institute for Advanced Science and Technology and an affiliate of the Carl R. Woese Institute for Genomic Biology.

Among other honors, Burke is a fellow of the American Association for the Advancement of Science and previously has been recognized with a Presidential Medal from the University of Illinois System, the Nobel Laureate Signature Award for Graduate Education in Chemistry from the American Chemical Society, and an Alfred P. Sloan Foundation research fellowship.  

Editor’s note: To reach Martin Burke, email mdburke@illinois.edu.  

Read Next

Announcements Graphic says: 2025 Highly Cited Researchers. Background is orange with an image of journal articles stacked and open.

Twelve Illinois scientists rank among the world’s most influential

CHAMPAIGN, Ill. — Twelve scientists at the University of Illinois Urbana-Champaign have been named to the 2025 Clarivate Analytics Highly Cited Researchers list. The list recognizes researchers and social scientists who have demonstrated exceptional influence, as reflected through their publication of multiple papers frequently cited by their peers during the last decade. The highly cited […]

Engineering A tilted view of miscellaneous of multicolored used batteries.

Study shows new hope for commercially attractive lithium extraction from spent batteries

A new study shows that lithium — a critical element used in rechargeable batteries and susceptible to supply chain disruption — can be recovered from battery waste using an electrochemically driven recovery process. The method has been tested on commonly used types of lithium-containing batteries and demonstrates economic viability with the potential to simplify operations, minimize costs and increase the sustainability and attractiveness of the recovery process for commercial use.

Health and Medicine Research team in the lab.

Study: A cellular protein, FGD3, boosts breast cancer chemotherapy, immunotherapy

CHAMPAIGN, Ill. — A naturally occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of some anticancer agents, including doxorubicin, one of the most widely used chemotherapies, and a preclinical drug known as ErSO, researchers report. The protein, FGD3, contributes to the rupture of cancer cells disrupted […]

Strategic Communications and Marketing News Bureau

507 E. Green St
MC-426
Champaign, IL 61820

Email: stratcom@illinois.edu

Phone (217) 333-5010